collaborators

8 papers

cs.CV2026

HEad and neCK TumOR (HECKTOR) 2025: Benchmark of Segmentation, Diagnosis, and Prognosis in Multimodal PET/CT

Numan Saeed, Salma Hassan, Shahad Hardan +27

Head and neck cancers (HNC) represent a significant global health burden, with accurate tumor delineation being essential for effective radiotherapy planning. The complexity of the…

eess.IV2026

Explaining Uncertainty in Multiple Sclerosis Cortical Lesion Segmentation Beyond Prediction Errors

Nataliia Molchanova, Pedro M. Gordaliza, Alessandro Cagol +14

Trustworthy artificial intelligence (AI) is essential in healthcare, particularly for high-stakes tasks like medical image segmentation. Explainable AI and uncertainty quantificati…

eess.IV2026

Instance-level quantitative saliency in multiple sclerosis lesion segmentation

Federico Spagnolo, Nataliia Molchanova, Meritxell Bach Cuadra +5

Explainable artificial intelligence (XAI) methods have been proposed to interpret model decisions in classification and, more recently, in semantic segmentation. However, instance-…

cs.CV2025

A Multimodal and Multi-centric Head and Neck Cancer Dataset for Segmentation, Diagnosis and Outcome Prediction

Numan Saeed, Salma Hassan, Shahad Hardan +40

We present a publicly available multimodal dataset for head and neck cancer research, comprising 1123 annotated Positron Emission Tomography/Computed Tomography (PET/CT) studies fr…

cs.CV2025

AI-based response assessment and prediction in longitudinal imaging for brain metastases treated with stereotactic radiosurgery

Lorenz Achim Kuhn, Daniel Abler, Jonas Richiardi +5

Brain Metastases (BM) are a large contributor to mortality of patients with cancer. They are treated with Stereotactic Radiosurgery (SRS) and monitored with Magnetic Resonance Imag…

cs.LG2025

The added value for MRI radiomics and deep-learning for glioblastoma prognostication compared to clinical and molecular information

D. Abler, O. Pusterla, A. Joye-Kühnis +19

Background: Radiomics shows promise in characterizing glioblastoma, but its added value over clinical and molecular predictors has yet to be proven. This study assessed the added v…